These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 37446317)

  • 1. Upregulation of the CD155-CD226 Axis Is Associated With Muscle Inflammation and Disease Severity in Idiopathic Inflammatory Myopathies.
    Li W; Deng C; Yang H; Tian X; Chen L; Liu Q; Gao C; Lu X; Wang G; Peng Q
    Neurol Neuroimmunol Neuroinflamm; 2023 Sep; 10(5):. PubMed ID: 37491355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare utilization and unmet needs of patients with antisynthetase syndrome: An international patient survey.
    Weiss M; Holzer MT; Muehlensiepen F; Ignatyev Y; Fiehn C; Bauhammer J; Schmidt J; Schlüter S; Dihkan A; Scheibner D; Schneider U; Valor-Mendez L; Corte G; Gupta L; Chinoy H; Lundberg I; Cavagna L; Distler JHW; Schett G; Knitza J
    Rheumatol Int; 2023 Oct; 43(10):1925-1934. PubMed ID: 37452880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic Inclusion Body Myositis at the Crossroads between Muscle Degeneration, Inflammation, and Aging.
    Guglielmi V; Cheli M; Tonin P; Vattemi G
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Unique microRNA Profiles in Different Types of Idiopathic Inflammatory Myopathy.
    Muñoz-Braceras S; Pinal-Fernandez I; Casal-Dominguez M; Pak K; Milisenda JC; Lu S; Gadina M; Naz F; Gutierrez-Cruz G; Dell'Orso S; Torres-Ruiz J; Grau-Junyent JM; Selva-O'Callaghan A; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
    Cells; 2023 Sep; 12(17):. PubMed ID: 37681930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
    Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
    Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion body myositis: from genetics to clinical trials.
    Nagy S; Khan A; Machado PM; Houlden H
    J Neurol; 2023 Mar; 270(3):1787-1797. PubMed ID: 36399165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum-Circulating microRNAs in Sporadic Inclusion Body Myositis.
    Lucchini M; De Arcangelis V; Santoro M; Morosetti R; Broccolini A; Mirabella M
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-192-5p Alleviated Fibrosis and Inflammatory Responses of Tendon Cells by Targeting NFAT5.
    Gong F; Li X; Zhang H; Wu J; Ma G; Zhang B; Gao J; Ding Y; Huang Y; Xia K; Cheng S; Zhou X; Shi J; Zhao F
    Comput Math Methods Med; 2022; 2022():6481846. PubMed ID: 35836925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis.
    Lucchini M; Maggi L; Pegoraro E; Filosto M; Rodolico C; Antonini G; Garibaldi M; Valentino ML; Siciliano G; Tasca G; De Arcangelis V; De Fino C; Mirabella M
    Cells; 2021 May; 10(5):. PubMed ID: 34068623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRTargetLink 2.0-interactive miRNA target gene and target pathway networks.
    Kern F; Aparicio-Puerta E; Li Y; Fehlmann T; Kehl T; Wagner V; Ray K; Ludwig N; Lenhof HP; Meese E; Keller A
    Nucleic Acids Res; 2021 Jul; 49(W1):W409-W416. PubMed ID: 34009375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Role of MiR-192-5p in Human Diseases.
    Ren FJ; Yao Y; Cai XY; Fang GY
    Front Pharmacol; 2021; 12():614068. PubMed ID: 33708127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies.
    Parkes JE; Thoma A; Lightfoot AP; Day PJ; Chinoy H; Lamb JA
    BMC Rheumatol; 2020; 4():25. PubMed ID: 32529172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zeb2 Regulates Myogenic Differentiation in Pluripotent Stem Cells.
    Di Filippo ES; Costamagna D; Giacomazzi G; Cortés-Calabuig Á; Stryjewska A; Huylebroeck D; Fulle S; Sampaolesi M
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.
    Peng H; Pan X; Su Q; Zhu LS; Ma GD
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8332-8344. PubMed ID: 31646563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pim1 kinase positively regulates myoblast behaviors and skeletal muscle regeneration.
    Liu Y; Shang Y; Yan Z; Li H; Wang Z; Liu Z; Li Z
    Cell Death Dis; 2019 Oct; 10(10):773. PubMed ID: 31601787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated expression profile of myomiRs in the skeletal muscle of patients with polymyositis.
    Zilahi E; Adamecz Z; Bodoki L; Griger Z; Póliska S; Nagy-Vincze M; Dankó K
    EJIFCC; 2019 Jun; 30(2):237-245. PubMed ID: 31372109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells.
    Xie X; Huang N; Zhang Y; Wei X; Gao M; Li M; Ning J; Liu W; Zhao Q; Wang H; Gu K
    J Cancer; 2019; 10(4):1039-1051. PubMed ID: 30854110
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.